{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T14:15:13Z","timestamp":1774620913650,"version":"3.50.1"},"reference-count":85,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 &amp; S\u00e9nologie\u00a0"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.gofs.2018.10.007","type":"journal-article","created":{"date-parts":[[2018,10,31]],"date-time":"2018-10-31T00:32:59Z","timestamp":1540945979000},"page":"823-833","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Contraception hormonale et risque vasculaire. RPC Contraception CNGOF"],"prefix":"10.1016","volume":"46","author":[{"given":"G.","family":"Plu-Bureau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Sabbagh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Hugon-Rodin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gofs.2018.10.007_bib0430","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/S0140-6736(61)91061-3","article-title":"Pulmonary embolism","volume":"278","author":"Jordan","year":"1961","journal-title":"Lancet"},{"key":"10.1016\/j.gofs.2018.10.007_bib0435","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.beem.2012.11.004","article-title":"History of oral contraceptive drugs and their use worldwide","volume":"27","author":"Christin-Maitre","year":"2013","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.gofs.2018.10.007_bib0440","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.contraception.2011.02.013","article-title":"Current issues and available options in combined hormonal contraception","volume":"84","author":"Bitzer","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.gofs.2018.10.007_bib0445","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.contraception.2010.04.004","article-title":"The use of newer progestins for contraception","volume":"82","author":"Sitruk-Ware","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.gofs.2018.10.007_bib0450","doi-asserted-by":"crossref","first-page":"f121","DOI":"10.1136\/bmj.f121","article-title":"French doctors are told to restrict use of third and fourth generation oral contraceptives","volume":"346","author":"Arie","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.gofs.2018.10.007_bib0455","doi-asserted-by":"crossref","first-page":"f279","DOI":"10.1136\/bmj.f279","article-title":"European agency defends existing advice on later generation contraceptive pills","volume":"346","author":"Arie","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.gofs.2018.10.007_bib0460","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1055\/s-0037-1613887","article-title":"Incidence of venous thromboembolism: a community-based study in Western France","volume":"83","author":"Oger","year":"2000","journal-title":"Thromb Haemost"},{"issue":"5","key":"10.1016\/j.gofs.2018.10.007_bib0465","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1160\/TH16-03-0205","article-title":"Current incidence of venous thromboembolism and comparison with 1998: a community-based study in Western France","volume":"116","author":"Delluc","year":"2016","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.gofs.2018.10.007_bib0470","doi-asserted-by":"crossref","first-page":"d6423","DOI":"10.1136\/bmj.d6423","article-title":"Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001\u20139","volume":"343","author":"Lidegaard","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.gofs.2018.10.007_bib0475","series-title":"L\u2019accident vasculaire c\u00e9r\u00e9bral en France\u00a0: patients hospitalis\u00e9s pour AVC en 2014\u00a0et \u00e9volution 2008\u20132014. BEH","author":"Lecoffre","year":"2017"},{"key":"10.1016\/j.gofs.2018.10.007_bib0480","series-title":"Infarctus du myocarde chez la femme\u00a0: \u00e9volutions des taux d\u2019hospitalisation et de mortalit\u00e9 en France 2002\u20132003. BEH","author":"Gabet","year":"2016"},{"key":"10.1016\/j.gofs.2018.10.007_bib0485","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/humupd\/5.6.721","article-title":"Cardiovascular disease and combined oral contraceptives: reviewing the evidence and balancing the risks","volume":"5","author":"Farley","year":"1999","journal-title":"Hum reprod Update"},{"key":"10.1016\/j.gofs.2018.10.007_bib0490","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0301-2115(00)00489-9","article-title":"Oral contraceptives, thrombosis and haemostasis","volume":"95","author":"Rosing","year":"2001","journal-title":"Eur J Obstet Gynecol reprod Biol"},{"key":"10.1016\/j.gofs.2018.10.007_bib0495","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.thromres.2016.03.025","article-title":"Duration of oral contraceptive use and the risk of venous thromboembolism. A case-control study","volume":"141","author":"Martinelli","year":"2016","journal-title":"Thromb Res"},{"key":"10.1016\/j.gofs.2018.10.007_bib0500","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmj.323.7305.131","article-title":"Third generation oral contraceptives and risk of venous thromboembolism","volume":"323","author":"Kemmeren","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.gofs.2018.10.007_bib0505","first-page":"7","article-title":"Venous and pulmonary thromboembolism and combined hormonal contraceptives. Systematic review and meta-analysis","volume":"17","author":"Martinez","year":"2012","journal-title":"Eur J Cont Trprod Health Care"},{"issue":"1","key":"10.1016\/j.gofs.2018.10.007_bib0510","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.beem.2012.11.002","article-title":"Hormonal contraceptives and venous thromboembolism: an epidemiological update","volume":"27","author":"Plu-Bureau","year":"2013","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.gofs.2018.10.007_bib0515","doi-asserted-by":"crossref","first-page":"f5298","DOI":"10.1136\/bmj.f5298","article-title":"Different combined oral contraceptives and the risk of venous thrombosis: systematic review and network meta-analysis","volume":"347","author":"Stegeman","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.gofs.2018.10.007_bib0520","first-page":"CD01081","article-title":"Combined oral contraceptives: venous thrombosis","volume":"3","author":"de Bastos","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.gofs.2018.10.007_bib0525","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/ijgo.12455","article-title":"A systematic review and meta-analysis of venous thrombosis risk among users of combined oral contraception","volume":"141","author":"Dragoman","year":"2018","journal-title":"Int J Gynecol Obstet"},{"key":"10.1016\/j.gofs.2018.10.007_bib0530","doi-asserted-by":"crossref","DOI":"10.1016\/j.thromres.2018.03.005","article-title":"Systematic review and meta-analysis of the association of combined oral contraceptives on the risk of venous thromboembolism: the role of the progestogen type and estrogen dose","author":"Oedingen","year":"2018","journal-title":"Thromb Res"},{"key":"10.1016\/j.gofs.2018.10.007_bib0535","doi-asserted-by":"crossref","first-page":"i2002","DOI":"10.1136\/bmj.i2002","article-title":"Low dose oestrogen combined oral contraception and risk of pulmonary embolism, stroke, and myocardial infarction in five million French women: cohort study","volume":"353","author":"Weill","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.gofs.2018.10.007_bib0540","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1093\/humupd\/dmt038","article-title":"The effect of combined oral contraception on testosterone levels in healthy women: a systematic review and meta-analysis","volume":"20","author":"Zimmerman","year":"2014","journal-title":"Hum Reprod Update"},{"issue":"6","key":"10.1016\/j.gofs.2018.10.007_bib0545","doi-asserted-by":"crossref","first-page":"R221","DOI":"10.1530\/EJE-14-0527","article-title":"Epidemiology of hormonal contraceptives-related venous thromboembolism","volume":"171","author":"Hugon-Rodin","year":"2014","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.1016\/j.gofs.2018.10.007_bib0550","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0010-7824(96)00112-6","article-title":"The increased risk of venous thromboembolism and the use of third generation progestagens: role of bias in observational research. The Transnational Research Group on Oral Contraceptives and the Health of Young Women","volume":"54","author":"Lewis","year":"1996","journal-title":"Contraception"},{"issue":"6","key":"10.1016\/j.gofs.2018.10.007_bib0555","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1093\/humrep\/14.6.1500","article-title":"Venous thromboembolic disease and combined oral contraceptives: a re-analysis of the MediPlus database","volume":"14","author":"Todd","year":"1999","journal-title":"Hum Reprod"},{"issue":"6","key":"10.1016\/j.gofs.2018.10.007_bib0560","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1046\/j.1365-2125.2000.00198.x","article-title":"A comparison of the risks of venous thromboembolic disease in association with different combined oral contraceptives","volume":"49","author":"Farmer","year":"2000","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.gofs.2018.10.007_bib0565","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0010-7824(01)00307-9","article-title":"Oral contraceptives and venous thromboembolism: a five-year national case-control study","volume":"65","author":"Lidegaard","year":"2002","journal-title":"Contraception"},{"issue":"6","key":"10.1016\/j.gofs.2018.10.007_bib0570","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.contraception.2006.02.002","article-title":"Risk of nonfatal venous thromboembolism with oral contraceptives containing norgestimate or desogestrel compared with oral contraceptives containing levonorgestrel","volume":"73","author":"Jick","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.gofs.2018.10.007_bib0855","first-page":"339","article-title":"The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen","volume":"13","author":"van Hylckama Vlieg","year":"2009","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.gofs.2018.10.007_bib0580","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1097\/AOG.0000000000000411","article-title":"Association of venous thromboembolism with hormonal contraception and thrombophilic genotypes","volume":"124","author":"Bergendal","year":"2014","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.gofs.2018.10.007_bib0585","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00404-013-2983-9","article-title":"Risk of benous thrombosis in users of hormonal contraceptives in German gynaecological practices: a patient database analysis","volume":"289","author":"Ziller","year":"2014","journal-title":"Arcg Gynecol Obstet"},{"key":"10.1016\/j.gofs.2018.10.007_bib0590","doi-asserted-by":"crossref","first-page":"h2135","DOI":"10.1136\/bmj.h2135","article-title":"Use of combined oral contraceptives and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases","volume":"350","author":"Vinogradova","year":"2015","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.gofs.2018.10.007_bib0595","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1783\/147118910791749416","article-title":"Risk of venous thromboembolism and the use of dienogest- and drospirenone-containing oral contraceptives: results from a German case-control study","volume":"36","author":"Dinger","year":"2010","journal-title":"J Fam Plann Reprod Health Care"},{"key":"10.1016\/j.gofs.2018.10.007_bib0600","unstructured":"FDA. Combined hormonal contraceptives (CHCs) and the risk of cardiovascular disease endpoints. CHC-CVD Final report 111022v2."},{"key":"10.1016\/j.gofs.2018.10.007_bib0605","doi-asserted-by":"crossref","first-page":"e2990","DOI":"10.1136\/bmj.e2990","article-title":"Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001\u201310","volume":"344","author":"Lidegaard","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.gofs.2018.10.007_bib0610","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.contraception.2016.10.005","article-title":"Nonoral combined hormonal contraceptives and thromboembolism: a systematic review","volume":"95","author":"Tepper","year":"2017","journal-title":"Contraception"},{"issue":"4","key":"10.1016\/j.gofs.2018.10.007_bib0615","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1097\/AOG.0b013e3182a5ec6b","article-title":"Cardiovascular risk associated with the use of an etonogestrel-containing vaginal ring","volume":"122","author":"Dinger","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.gofs.2018.10.007_bib0620","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(94)90286-0","article-title":"Increased risk of venous thrombosis in oral-contraceptive. users who are carriers of factor V Leiden mutation","volume":"334","author":"Vandenbroucke","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.gofs.2018.10.007_bib0625","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1160\/TH04-11-0759","article-title":"Oral contraceptives, hormone replacement therapy, thrombophilias and risk of venous thromboembolism: a systematic review. The thrombosis: risk and economic assessment of thrombophilia Screening (TREATS) study","volume":"94","author":"Wu","year":"2005","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.gofs.2018.10.007_bib0630","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1111\/jth.13349","article-title":"Combined oral contraceptives, thrombophilia and the risk of venous thromboembolism: a systematic review and meta-analysis","volume":"14","author":"van Vlijmen","year":"2016","journal-title":"J Thromb Haemost"},{"issue":"5","key":"10.1016\/j.gofs.2018.10.007_bib0635","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1055\/s-0038-1641152","article-title":"Type of combined contraceptives, factor V Leiden mutation and risk of venous thromboembolism","volume":"118","author":"Hugon-Rodin","year":"2018","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.gofs.2018.10.007_bib0640","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1161\/CIRCULATIONAHA.110.965020","article-title":"Age- and gender-specific familial risks for venous thromboembolism: a nationwide epidemiological study based on hospitalizations in Sweden","volume":"124","author":"Z\u00f6ller","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.gofs.2018.10.007_bib0645","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12959-015-0065-x","article-title":"Family history of venous thromboembolism is a risk factor for venous thromboembolism in combined oral contraceptive users: a nationwide case-control study","volume":"13","author":"Z\u00f6ller","year":"2015","journal-title":"Thromb J"},{"key":"10.1016\/j.gofs.2018.10.007_bib0650","doi-asserted-by":"crossref","DOI":"10.1111\/jth.13393","article-title":"The impact of a male of female thrombotic family history on contraceptive counselling: a cohort study","author":"van Vlijmen","year":"2016","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.gofs.2018.10.007_bib0655","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.contraception.2008.11.002","article-title":"Sex hormone-binding globulin: an adequate marker for venous thromboembolism in women using new hormonal contraceptives","volume":"79","author":"van Vliet","year":"2009","journal-title":"Contraception"},{"issue":"6","key":"10.1016\/j.gofs.2018.10.007_bib0660","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1111\/j.1538-7836.2012.04720.x","article-title":"Sex hormone-binding globulin as a marker for the thrombotic risk of hormonal contraceptives","volume":"10","author":"Raps","year":"2012","journal-title":"J Thromb Haemost"},{"issue":"2","key":"10.1016\/j.gofs.2018.10.007_bib0665","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2165\/11591200-000000000-00000","article-title":"Hemostatic effects of a novel estradiol-based oral contraceptive: an open-label, randomized, crossover study of estradiol valerate\/dienogest versus ethinylestradiol\/levonorgestrel","volume":"11","author":"Klipping","year":"2011","journal-title":"Drugs R D"},{"key":"10.1016\/j.gofs.2018.10.007_bib0670","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1160\/TH10-05-0327","article-title":"Haemostatic effects of a new combined oral contraceptive, nomegestrol acetate\/17b estradiol compared with those of levonorgestrel\/ethinyl estradiol","volume":"105","author":"Gaussem","year":"2011","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.gofs.2018.10.007_bib0675","doi-asserted-by":"crossref","first-page":"444","DOI":"10.3109\/13625187.2011.604450","article-title":"Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17b estradiol compared with one containing levonorgestrel and ethinyl estradiol on haemostasis, lipids and carbohydrate metabolism","volume":"16","author":"Agren","year":"2011","journal-title":"Eur J Contr Reprod Health care"},{"key":"10.1016\/j.gofs.2018.10.007_bib0680","doi-asserted-by":"crossref","first-page":"e4944","DOI":"10.1136\/bmj.e4944","article-title":"Assessing the risk of venous thromboembolic events in women taking progestin-only contraception: a meta-analysis","volume":"345","author":"Mantha","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.gofs.2018.10.007_bib0685","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1136\/bmj.280.6224.1157","article-title":"Progestogens and cardiovascular reactions associated <ith oral contraceptives and a comparison of the safety of 50- and 30-microgram oestrogen preparations","volume":"280","author":"Meade","year":"1980","journal-title":"Br Med J"},{"key":"10.1016\/j.gofs.2018.10.007_bib0690","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1538-7836.2010.04148.x","article-title":"Hormone therapies and venous thromboembolism: where are we now?","volume":"9","author":"van Hylckama Vlieg","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.gofs.2018.10.007_bib0695","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1210\/jc.2004-1958","article-title":"Association between the current use of low-dose oral contraceptives and cardiovascular arterial disease: a meta-analysis","volume":"90","author":"Baillargeon","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.gofs.2018.10.007_bib0700","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0010-7824(03)00073-8","article-title":"Oral contraceptives use and the risk of myocardial infarction: a meta-analysis","volume":"68","author":"Khader","year":"2003","journal-title":"Contraception"},{"key":"10.1016\/j.gofs.2018.10.007_bib0705","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1001\/jama.284.1.72","article-title":"Ischemic stroke risk with oral contraceptives: a meta-analysis","volume":"284","author":"Gillum","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.gofs.2018.10.007_bib0710","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.beem.2012.11.003","article-title":"Hormonal contraceptives and arterial disease: an epidemiological update","volume":"27","author":"Plu-Bureau","year":"2013","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"2\u00a0Pt 1","key":"10.1016\/j.gofs.2018.10.007_bib0715","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/AOG.0b013e3182994c43","article-title":"Risk of acute thromboembolic events with oral contraceptive use: a systematic review and meta-analysis","volume":"122","author":"Peragallo Urrutia","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.gofs.2018.10.007_bib0720","first-page":"CD011054","article-title":"Combined oral contraceptives: the risk of myocardial infarction and ischemic stroke","author":"Roach","year":"2015","journal-title":"Cochrane Database Syst rev"},{"issue":"24","key":"10.1016\/j.gofs.2018.10.007_bib0725","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1056\/NEJMoa1111840","article-title":"Thrombotic stroke and myocardial infarction with hormonal contraception","volume":"366","author":"Lidegaard","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.gofs.2018.10.007_bib0730","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1210\/jc.2010-2065","article-title":"Progestogen-only contraceptives and the risk of acute myocardial infarction: a meta-analysis","volume":"96","author":"Chakhtoura","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.gofs.2018.10.007_bib0735","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1161\/STROKEAHA.108.538405","article-title":"Progestogen-only contraceptives and the risk of stroke: a meta-analysis","volume":"40","author":"Chaktoura","year":"2009","journal-title":"Stroke"},{"issue":"3","key":"10.1016\/j.gofs.2018.10.007_bib0740","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0010-7824(00)00159-1","article-title":"Oral contraception and cardiovascular risk factors during adolescence","volume":"62","author":"Paulus","year":"2000","journal-title":"Contraception"},{"issue":"3","key":"10.1016\/j.gofs.2018.10.007_bib0745","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0895-4356(94)90015-9","article-title":"Smoking among oral contraceptive users in Quebec in 1987","volume":"47","author":"Sharpe","year":"1994","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.gofs.2018.10.007_bib0750","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1056\/NEJMoa003216","article-title":"Oral contraceptives and the risk of myocardial infarction","volume":"345","author":"Tanis","year":"2001","journal-title":"NEJM"},{"issue":"8119","key":"10.1016\/j.gofs.2018.10.007_bib0755","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0140-6736(79)91205-4","article-title":"Oral-contraceptive use in relation to myocardial infarction","volume":"1","author":"Shapiro","year":"1979","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.gofs.2018.10.007_bib0760","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1093\/ije\/18.3.585","article-title":"Myocardial infarction in young women with reference to oral contraceptive use","volume":"18","author":"Ananijevi\u0107-Pandey","year":"1989","journal-title":"Int J Epidemiol"},{"issue":"9060","key":"10.1016\/j.gofs.2018.10.007_bib0765","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/S0140-6736(97)02358-1","article-title":"Acute myocardial infarction and combined oral contraceptives: results of an international multicentre case-control study. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception","volume":"349","author":"WHO.","year":"1997","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.gofs.2018.10.007_bib0770","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1001\/archinte.161.8.1065","article-title":"Low-dose oral contraceptive use and the risk of myocardial infarction","volume":"161","author":"Rosenberg","year":"2001","journal-title":"Arch Intern Med"},{"issue":"3","key":"10.1016\/j.gofs.2018.10.007_bib0775","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0010-7824(97)00118-2","article-title":"The use of oral contraceptives and the occurrence of acute myocardial infarction in young women. Results from the Transnational Study on Oral Contraceptives and the Health of Young Women","volume":"56","author":"Lewis","year":"1997","journal-title":"Contraception"},{"issue":"8","key":"10.1016\/j.gofs.2018.10.007_bib0780","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1111\/j.1471-0528.1998.tb10235.x","article-title":"Risk of myocardial infarction, angina and stroke in users of oral contraceptives: an updated analysis of a cohort study","volume":"105","author":"Mant","year":"1998","journal-title":"Br J Obstet Gynaecol"},{"issue":"2","key":"10.1016\/j.gofs.2018.10.007_bib0785","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.fertnstert.2006.11.206","article-title":"A prospective study of oral contraceptive use and risk of myocardial infarction among Swedish women","volume":"88","author":"Margolis","year":"2007","journal-title":"Fertil Steril"},{"issue":"9026","key":"10.1016\/j.gofs.2018.10.007_bib0790","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0140-6736(95)12393-8","article-title":"Ischaemic stroke and combined oral contraceptives: results of an international, multicentre, case-control study. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception","volume":"348","author":"WHO.","year":"1996","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.gofs.2018.10.007_bib0795","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1161\/01.STR.29.11.2277","article-title":"Stroke and use of low-dose oral contraceptives in young women: a pooled analysis of two US studies","volume":"29","author":"Schwartz","year":"1998","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.gofs.2018.10.007_bib0800","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0010-7824(97)00204-7","article-title":"Thromboembolic stroke in young women. A European case-control study on oral contraceptives. Transnational Research Group on Oral Contraceptives and the Health of Young Women","volume":"57","author":"Heinemann","year":"1998","journal-title":"Contraception"},{"key":"10.1016\/j.gofs.2018.10.007_bib0805","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1161\/STROKEAHA.113.004023","article-title":"Prevention opportunities for oral contraceptive-associated ischemic stroke","volume":"45","author":"Ryan","year":"2014","journal-title":"Stroke"},{"issue":"5","key":"10.1016\/j.gofs.2018.10.007_bib0810","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1161\/01.STR.25.5.935","article-title":"Oral contraception and stroke. Evidence from the Royal College of General Practitioners\u2019 Oral Contraception Study","volume":"25","author":"Hannaford","year":"1994","journal-title":"Stroke"},{"issue":"10127","key":"10.1016\/j.gofs.2018.10.007_bib0815","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/S0140-6736(18)30478-1","article-title":"Migraine","volume":"391","author":"Dodick","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.gofs.2018.10.007_bib0820","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S0140-6736(16)31678-6","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 310\u00a0diseases and injuries 1990\u20132015: a systematic analysis for the Global Burden of Disease Study 2015","volume":"388","author":"GBD 2015\u00a0Disease Injury Incidence Prevalence Collaborators.","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.gofs.2018.10.007_bib0825","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S1474-4422(17)30299-5","article-title":"Global, regional, and national burden of neurological disorders during 1990\u20132015: a systematic analysis for the Global Burden of Disease Study 2015","volume":"16","author":"GBD 2015\u00a0Neurological Disorders Collaborator Group.","year":"2017","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.gofs.2018.10.007_bib0830","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1136\/bmj.38302.504063.8F","article-title":"Risk of ischaemic stroke in people with migraine: systematic review and meta-analysis of observational studies","volume":"330","author":"Etminan","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.gofs.2018.10.007_bib0835","doi-asserted-by":"crossref","first-page":"b3914","DOI":"10.1136\/bmj.b3914","article-title":"Migraine and cardiovascular disease: systematic review and metaanalysis","volume":"339","author":"Sch\u00fcrks","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.gofs.2018.10.007_bib0840","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/head.12035","article-title":"Contraception and headache","volume":"53","author":"MacGregor","year":"2013","journal-title":"Headache"},{"issue":"5","key":"10.1016\/j.gofs.2018.10.007_bib0845","doi-asserted-by":"crossref","first-page":"489e1","DOI":"10.1016\/j.ajog.2016.12.019","article-title":"Use of combined hormonal contraceptives among women with migraines and risk of ischemic stroke","volume":"216","author":"Champaloux","year":"2017","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.gofs.2018.10.007_bib0850","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s10194-017-0815-1","volume":"18","author":"Sacco","year":"2017","journal-title":"J Headache Pain"}],"container-title":["Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 &amp; S\u00e9nologie\u00a0"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468718918302629?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468718918302629?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T19:24:39Z","timestamp":1551209079000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468718918302629"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":85,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S2468718918302629"],"URL":"https:\/\/doi.org\/10.1016\/j.gofs.2018.10.007","relation":{},"ISSN":["2468-7189"],"issn-type":[{"value":"2468-7189","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Contraception hormonale et risque vasculaire. RPC Contraception CNGOF","name":"articletitle","label":"Article Title"},{"value":"Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gofs.2018.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}